Want to see HK:2185 full AI Analyst Report?
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (2185) Financial Statements
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H Financial Overview
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H's market cap is currently $226.38M. The company's EPS TTM is $-0.31; its P/E ratio is -2.54; Shanghai Bio-Heart Biological Technology Co., Ltd. Class H has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 43.77M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -157.81K | $ 0.00 | $ -23.60M | $ -24.25M | $ -13.27M |
| Operating Income | $ -69.84M | $ -61.04M | $ -164.62M | $ -293.28M | $ -409.65M |
| EBITDA | $ -52.13M | $ -52.87M | $ -143.27M | $ -229.43M | $ -396.42M |
| Net Income | $ -68.24M | $ -87.94M | $ -175.89M | $ -204.24M | $ -361.45M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 248.63M | $ 202.39M | $ 369.44M | $ 451.32M | $ 708.53M |
| Total Assets | $ 832.83M | $ 733.78M | $ 817.90M | $ 981.52M | $ 1.11B |
| Total Debt | $ 12.73M | $ 8.28M | $ 1.76M | $ 18.11M | $ 22.45M |
| Net Debt | $ -79.59M | $ -194.10M | $ -367.68M | $ -433.21M | $ -686.09M |
| Total Liabilities | $ 220.47M | $ 53.24M | $ 44.04M | $ 66.47M | $ 80.04M |
| Stockholders' Equity | $ 435.00M | $ 660.47M | $ 748.41M | $ 883.21M | $ 995.69M |
| Cash Flow | |||||
| Free Cash Flow | $ -72.91M | $ -166.69M | $ -66.74M | $ -170.65M | $ -147.28M |
| Operating Cash Flow | $ -65.48M | $ -119.55M | $ -49.03M | $ -140.62M | $ -88.47M |
| Investing Cash Flow | $ -39.78M | $ -46.03M | $ -28.86M | $ -100.69M | $ -33.73M |
| Financing Cash Flow | $ -1.74M | $ -2.44M | $ -5.82M | $ -35.18M | $ 383.68M |
Currency in CNY
